Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Jackie Reeve, Kaitlyn Wells and Melanie Pinola You can find plenty of phone ...
Join Miami University's Project Dragonfly and ignite ecological and social change. Our innovative master's programs and professional development opportunities blend flexible online learning with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback